Evgen Pharma (GB:TCF) has released an update.
Theracryf PLC has reported a significant change in their shareholding structure, with First Equity Limited and Armstrong Investments Limited, both UK-based entities, now controlling a combined total of 5.43% of the voting rights as of July 15, 2024. This marks an increase from the previous notification, reflecting a shift in the investment landscape of Theracryf. The notification was completed on July 16, 2024, in London.
For further insights into GB:TCF stock, check out TipRanks’ Stock Analysis page.
